-
The government has asked India’s drugmakers to step up as global supply chains get redesigned, shifting the pitch from “largest supplier” to most trusted supplier. Speaking at the 11th Global Pharmaceutical Quality Summit, Union minister JP Nadda said India must lead the new supply-chain order with quality, reliability and innovation, warning that “trust will define leadership” as countries diversify away from single-source dependencies post-Covid and amid geopolitical churn.
The message wasn’t just rhetoric: Nadda linked competitiveness to regulatory excellence and global standards alignment, pushing the industry toward quality-first manufacturing and tighter, audit-ready processes that can withstand global scrutiny. He also pointed to India’s push on new technologies for early disease detection and diagnostics, signalling that the next phase of growth will come from capability upgrades, not just output volume.
